After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Jazz Pharmaceuticals plc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Jazz Pharmaceuticals plc is $8.44B. A total of 1.27 million shares were traded on the day, compared to an average of 601.25K shares.
In the most recent transaction, COZADD BRUCE C sold 1,500 shares of JAZZ for 122.31 per share on Feb 03 ’25. After the transaction, the Chairman & CEO now owns 439,744 company shares. In a previous transaction on Feb 03 ’25, COZADD BRUCE C bought 1,500 shares at 122.31 per share.
Among the insiders who sold shares, COZADD BRUCE C disposed of 1,500 shares on Jan 02 ’25 at a per-share price of $123.43. This resulted in the Chairman & CEO holding 425,525 shares of JAZZ after the transaction. In another insider transaction, COZADD BRUCE C bought 1,500 shares at $123.43 per share on Jan 02 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, JAZZ has a high of $138.27 and a low of $99.06.
As of this writing, JAZZ has an earnings estimate of $4.6 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $4.6 per share and a lower estimate of $4.6.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. JAZZ’s latest balance sheet shows that the firm has $591.45M in Cash & Short Term Investments as of fiscal 2021. There were $6.15B in debt and $809.30M in liabilities at the time. Its Book Value Per Share was $69.01, while its Total Shareholder’s Equity was $3.97B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JAZZ is Buy with a score of 4.63.
